Madison, WI 2/15/12—A jury in the US District Court for the Western District of Wisconsin has awarded Promega $52.0 million in damages for willful infringement of its Short Tandem Repeat (STR) patents by Life Technologies. The Court may increase the damages and will consider an injunction against Life Technologies for the sale of the infringing […]
In the calendar-year fourth quarter, major, publicly held US instrument companies posted steady growth. In general, US academic and government sales improved from the third quarter but remained slow, according to several companies. The surprise of the quarter was Europe, for which a number of firms reported sales growth. For the eight businesses whose results […]
As discussed in IBO’s August 15, 2011, issue, China’s 12th Five-Year Plan was initiated last year, with the aim of boosting the country’ R&D spending to 2.2% of GDP, compared with 1.8% of GDP in 2010. Details of the specific industry and regional five-year plans continue to be announced, including the funding amounts and goals […]
The Dow Jones Industrial Average traded above 13,000 in February for the first time since April 2008. Market momentum was stimulated by employment growth, manufacturing data, rising consumer sentiment and strong technology earnings. On February 29, fourth-quarter GDP growth was revised up to 3.0% from initial estimates of 2.8%. However, concerns emerged as economic data […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
